ADALIMUMAB — all Canadian products

46 DINs

45 marketed/approved

0 in shortage

Every Health Canada Drug Identification Number whose active ingredient is ADALIMUMAB, with holder, form, strength and current status, compared weekly against the Drug Product Database.

DIN	Product	Company	Form	Route	Strength	Status
02511088	ABRILADA	PFIZER CANADA ULC	Solution	Subcutaneous	ADALIMUMAB 10 MG	Approved
02511053	ABRILADA	PFIZER CANADA ULC	Solution	Subcutaneous	ADALIMUMAB 40 MG	Marketed
02511045	ABRILADA	PFIZER CANADA ULC	Solution	Subcutaneous	ADALIMUMAB 40 MG	Marketed
02511061	ABRILADA	PFIZER CANADA ULC	Solution	Subcutaneous	ADALIMUMAB 20 MG	Marketed
02511096	ABRILADA	PFIZER CANADA ULC	Solution; Kit	Subcutaneous	ADALIMUMAB 40 MG	Approved
02570009	AMGEVITA	AMGEN CANADA INC	Solution	Subcutaneous	ADALIMUMAB 20 MG	Approved
02459302	AMGEVITA	AMGEN CANADA INC	Solution	Subcutaneous	ADALIMUMAB 50 MG	Marketed
02459310	AMGEVITA	AMGEN CANADA INC	Solution	Subcutaneous	ADALIMUMAB 50 MG	Marketed
02570041	AMGEVITA	AMGEN CANADA INC	Solution	Subcutaneous	ADALIMUMAB 80 MG	Approved
02570033	AMGEVITA	AMGEN CANADA INC	Solution	Subcutaneous	ADALIMUMAB 80 MG	Approved
02459299	AMGEVITA	AMGEN CANADA INC	Solution	Subcutaneous	ADALIMUMAB 50 MG	Marketed
02570025	AMGEVITA	AMGEN CANADA INC	Solution	Subcutaneous	ADALIMUMAB 40 MG	Approved
02570017	AMGEVITA	AMGEN CANADA INC	Solution	Subcutaneous	ADALIMUMAB 40 MG	Approved
02533472	HADLIMA	SAMSUNG BIOEPIS CO., LTD	Solution	Subcutaneous	ADALIMUMAB 40 MG	Marketed
02473097	HADLIMA	SAMSUNG BIOEPIS CO., LTD	Solution	Subcutaneous	ADALIMUMAB 40 MG	Marketed
02533480	HADLIMA PUSHTOUCH	SAMSUNG BIOEPIS CO., LTD	Solution	Subcutaneous	ADALIMUMAB 40 MG	Marketed
02473100	HADLIMA PUSHTOUCH	SAMSUNG BIOEPIS CO., LTD	Solution	Subcutaneous	ADALIMUMAB 40 MG	Marketed
02502402	HULIO	BIOCON BIOLOGICS CANADA INC	Solution	Subcutaneous	ADALIMUMAB 40 MG	Marketed
02502399	HULIO	BIOCON BIOLOGICS CANADA INC	Solution	Subcutaneous	ADALIMUMAB 40 MG	Marketed
02502380	HULIO	BIOCON BIOLOGICS CANADA INC	Solution	Subcutaneous	ADALIMUMAB 20 MG	Marketed
02458349	HUMIRA	ABBVIE CORPORATION	Solution	Subcutaneous	ADALIMUMAB 40 MG	Marketed
02258595	HUMIRA	ABBVIE CORPORATION	Solution	Subcutaneous	ADALIMUMAB 40 MG	Marketed
02466872	HUMIRA	ABBVIE CORPORATION	Solution	Subcutaneous	ADALIMUMAB 80 MG	Approved
02474220	HUMIRA	ABBVIE CORPORATION	Solution	Subcutaneous	ADALIMUMAB 80 MG	Approved
02474255	HUMIRA	ABBVIE CORPORATION	Solution	Subcutaneous	ADALIMUMAB 10 MG	Approved
02474263	HUMIRA	ABBVIE CORPORATION	Solution	Subcutaneous	ADALIMUMAB 20 MG	Marketed
02458357	HUMIRA	ABBVIE CORPORATION	Solution	Subcutaneous	ADALIMUMAB 40 MG	Marketed
02542323	HYRIMOZ	SANDOZ CANADA INCORPORATED	Solution	Subcutaneous	ADALIMUMAB 40 MG	Marketed
02492156	HYRIMOZ	SANDOZ CANADA INCORPORATED	Solution	Subcutaneous	ADALIMUMAB 40 MG	Marketed
02492164	HYRIMOZ	SANDOZ CANADA INCORPORATED	Solution	Subcutaneous	ADALIMUMAB 40 MG	Marketed
02505258	HYRIMOZ	SANDOZ CANADA INCORPORATED	Solution	Subcutaneous	ADALIMUMAB 20 MG	Marketed
02542315	HYRIMOZ	SANDOZ CANADA INCORPORATED	Solution	Subcutaneous	ADALIMUMAB 20 MG	Marketed
02542331	HYRIMOZ	SANDOZ CANADA INCORPORATED	Solution	Subcutaneous	ADALIMUMAB 40 MG	Marketed
02542358	HYRIMOZ	SANDOZ CANADA INCORPORATED	Solution	Subcutaneous	ADALIMUMAB 80 MG	Marketed
02542366	HYRIMOZ	SANDOZ CANADA INCORPORATED	Solution	Subcutaneous	ADALIMUMAB 80 MG	Marketed
02502682	IDACIO	FRESENIUS KABI CANADA LTD	Solution	Subcutaneous	ADALIMUMAB 40 MG	Marketed
02502674	IDACIO	FRESENIUS KABI CANADA LTD	Solution	Subcutaneous	ADALIMUMAB 40 MG	Marketed
02523957	SIMLANDI	JAMP PHARMA CORPORATION	Solution	Subcutaneous	ADALIMUMAB 40 MG	Marketed
02523949	SIMLANDI	JAMP PHARMA CORPORATION	Solution	Subcutaneous	ADALIMUMAB 40 MG	Marketed
02523965	SIMLANDI	JAMP PHARMA CORPORATION	Solution	Subcutaneous	ADALIMUMAB 80 MG	Marketed
02523779	YUFLYMA	CELLTRION INC.	Solution	Subcutaneous	ADALIMUMAB 40 MG	Marketed
02523760	YUFLYMA	CELLTRION INC.	Solution	Subcutaneous	ADALIMUMAB 40 MG	Marketed
02556596	YUFLYMA	CELLTRION INC.	Solution	Subcutaneous	ADALIMUMAB 20 MG	Approved
02535076	YUFLYMA	CELLTRION INC.	Solution	Subcutaneous	ADALIMUMAB 80 MG	Marketed
02535084	YUFLYMA	CELLTRION INC.	Solution	Subcutaneous	ADALIMUMAB 80 MG	Marketed
02502666	IDACIO	FRESENIUS KABI CANADA LTD	Solution	Subcutaneous	ADALIMUMAB 40 MG	Cancelled Pre Market

Request a quote for ADALIMUMAB

Browse other molecules:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z